Biochemical and functional characterization of three activated macrophage populations

Journal of Leukocyte Biology

Volumn 80, Issue 6, 2006, Pages 1298-1307

  Edwards, Justin P ^a   Zhang, Xia ^a   Frauwirth, Kenneth A ^a   Mosser, David M ^a  

^a Bldg 142   (United States)

Author keywords

IL 10.IL 12; LIGHT; Sphingosine kinase

Indexed keywords

APRIL PROTEIN; BIOCHEMICAL MARKER; CALCIUM; CD86 ANTIGEN; CELL CYCLE PROTEIN 20; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SPHINGOSINE KINASE 1; TUMOR NECROSIS SUPERFAMILY 14;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FUNCTIONAL ASSESSMENT; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL;

ANIMALS; ANTIGENS, CD86; ARGINASE; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; NERVE GROWTH FACTOR; NITRIC OXIDE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEINS; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

EID: 33845398215     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0406249     Document Type: Article

References (46)

1. Lang, R., Patel, D., Morris, J. J., Rutschman, R. L., Murray, P. J. (2002) Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169, 2253-2263.
2. David, J. R. (1975) Macrophage activation by lymphocyte mediators. Fed. Proc. 34, 1730-1736.
3. Akira, S., Uematsu, S., Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801.
4. Oppenheim, J. J., Yang, D. (2005) Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359-365.
5. Nathan, C., Shiloh, M. U. (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97, 8841-8848.
6. Stein, M., Keshav, S., Harris, N., Gordon, S. (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292.
7. Raes, G., Noel, W., Beschin, A., Brys, L., de Baetselier, P., Hassanzadeh, G. H. (2002) FIZZ1 and Ym as tools to discriminate between differentially activated macrophages. Dev. Immunol. 9, 151-159.
8. Hesse, M., Modolell, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J., Wynn, T. A. (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167, 6533-6544.
9. Albina, J. E., Mills, C. D., Henry Jr., W. L., Caldwell, M. D. (1990) Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J. Immunol. 144, 3877-3880.
10. Gerber, J. S., Mosser, D. M. (2001) Reversing lipopolysaccharide toxicity by ligating the macrophage Fc γ receptors. J. Immunol. 166, 6861-6868.
11. Anderson, C. F., Mosser, D. M. (2002) Cutting edge: biasing immune responses by directing antigen to macrophage Fc γ receptors. J. Immunol. 168, 3697-3701.
12. Anderson, C. F., Mosser, D. M. (2002) A novel phenotype for an activated macrophage: the type 2 activated macrophage. J. Leukoc. Biol. 72, 101-106.
13. Miles, S. A., Conrad, S. M., Alves, R. G., Jeronimo, S. M., Mosser, D. M. (2005) A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J. Exp. Med. 201, 747-754.
14. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555.
15. Frankenberger, M., Haussinger, K., Ziegler-Heitbrock, L. (2005) Liposomal methylprednisolone differentially regulates the expression of TNF and IL-10 in human alveolar macrophages. Int. Immunopharmacol. 5, 289-299.
16. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
17. Biswas, S. K., Gangi, L., Paul, S., Schioppa, T., Saccani, A., Sironi, M., Bottazzi, B., Doni, A., Vincenzo, B., Pasqualini, F., Vago, L., Nebuloni, M., Mantovani, A., Sica, A. (2006) A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood 107, 2112-2122.
18. Skeen, M. J., Miller, M. A., Shinnick, T. M., Ziegler, H. K. (1996) Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J. Immunol. 156, 1196-1206.
19. Murphy, K. M., Heimberger, A. B., Loh, D. Y. (1990) Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250, 1720-1723.
20. Johnson, C. R., Kitz, D., Little, J. R. (1983) A method for the derivation and continuous propagation of cloned murine bone marrow macrophages. J. Immunol. Methods 65, 319-332.
21. Stuehr, D. J., Nathan, C. F. (1989) Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169, 1543-1555.
22. Corraliza, I. M., Campo, M. L., Soler, G., Modolell, M. (1994) Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 174, 231-235.
23. Anderson, C. F., Mosser, D. M. (2002) A novel phenotype for an activated macrophage: the type 2 activated macrophage. J. Leukoc. Biol. 72, 101-106.
24. Schebesch, C., Kodelja, V., Muller, C., Hakij, N., Bisson, S., Orfanos, C. E., Goerdt, S. (1997) Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology 92, 478-486.
25. Kambayashi, T., Jacob, C. O., Strassmann, G. (1996) IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. Cell. Immunol. 171, 153-158.
26. Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., Suttles, J. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349.
27. Modolell, M., Corraliza, I. M., Link, F., Soler, G., Eichmann, K. (1995) Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 25, 1101-1104.
28. Holcomb, I. N., Kabakoff, R. C., Chan, B., Baker, T. W., Gurney, A., Henzel, W., Nelson, C., Lowman, H. B., Wright, B. D., Skelton, N. J., Frantz, G. D., Tumas, D. B., Peale Jr., F. V., Shelton, D. L., Herbert, C. C. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19, 4046-4055.
29. Mortarini, R., Scarito, A., Nonaka, D., Zanon, M., Bersani, I., Montaldi, E., Pennacchioli, E., Patuzzo, R., Santinami, M., Anichini, A. (2005) Constitutive expression and costimulatory function of LIGHT/TNFSF14 on human melanoma cells and melanoma-derived microvesicles. Cancer Res. 65, 3428-3436.
30. Chao, C. C., Jensen, R., Dailey, M. O. (1997) Mechanisms of L-selectin regulation by activated T cells. J. Immunol. 159, 1686-1694.
31. Lowenthal, J. W., Zubler, R. H., Nabholz, M., MacDonald, H. R. (1985) Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature 315, 669-672.
32. Yokoyama, W. M., Koning, F., Kehn, P. J., Pereira, G. M., Stingl, G., Coligan, J. E., Shevach, E. M. (1988) Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. J. Immunol. 141, 369-376.
33. Nair, M. G., Gallagher, I. J., Taylor, M. D., Loke, P., Coulson, P. S., Wilson, R. A., Maizels, R. M., Allen, J. E. (2005) Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect. Immun. 73, 385-394.
34. Gratchev, A., Guillot, P., Hakiy, N., Politz, O., Orfanos, C. E., Schledzewski, K., Goerdt, S. (2001) Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein IG-H3. Scand. J. Immunol. 53, 386-392.
35. Kodelja, V., Muller, C., Politz, O., Hakij, N., Orfanos, C. E., Goerdt, S. (1998) Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 α with a Th2-associated expression pattern. J. Immunol. 160, 1411-1418.
36. Willment, J. A., Lin, H. H., Reid, D. M., Taylor, P. R., Williams, D. L., Wong, S. Y., Gordon, S., Brown, G. D. (2003) Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J. Immunol. 171, 4569-4573.
37. Scotton, C. J., Martinez, F. O., Smelt, M. J., Sironi, M., Locati, M., Mantovani, A., Sozzani, S. (2005) Transcriptional profiling reveals complex regulation of the monocyte IL-1 β system by IL-13. J. Immunol. 174, 834-845.
38. Brys, L., Beschin, A., Raes, G., Ghassabeh, G. H., Noel, W., Brandt, J., Brombacher, F., De Baetselier, P. (2005) Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection. J. Immunol. 174, 6095-6104.
39. Tamada, K., Shimozaki, K., Chapoval, A. I., Zhai, Y., Su, J., Chen, S. F., Hsieh, S. L., Nagata, S., Ni, J., Chen, L. (2000) LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 164, 4105-4110.
40. Kwon, B. S., Tan, K. B., Ni, J., Oh, K. O., Lee, Z. H., Kim, K. K., Kim, Y. J., Wang, S., Gentz, R., Yu, G. L., Harrop, J., Lyn, S. D., Silverman, C., Porter, T. G., Truneh, A., Young, P. R. (1997) A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 272, 14272-14276.
41. Shi, G., Luo, H., Wan, X., Salcedo, T. W., Zhang, J., Wu, J. (2002) Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 100, 3279-3286.
42. Wan, X., Zhang, J., Luo, H., Shi, G., Kapnik, E., Kim, S., Kanakaraj, P., Wu, J. A. (2002) TNF family member LIGHT transduces costimulatory signals into human T cells. J. Immunol. 169, 6813-6821.
43. Kihara, A., Anada, Y., Igarashi, Y. (2006) Mouse sphingosine kinase isoforms SPHK1a and SPHK1b differ in enzymatic traits including stability, localization, modification, and oligomerization. J. Biol. Chem. 281, 4532-4539.
44. Melendez, A. J., Ibrahim, F. B. (2004) Antisense knockdown of sphingosine kinase 1 in human macrophages inhibits C5a receptor-dependent signal transduction, Ca2+ signals, enzyme release, cytokine production, and chemotaxis. J. Immunol. 173, 1596-1603.
45. Wu, W., Mosteller, R. D., Broek, D. (2004) Sphingosine kinase protects lipopolysaccharide-activated macrophages from apoptosis. Mol. Cell. Biol. 24, 7359-7369.
46. Yang, J., Castle, B. E., Hanidu, A., Stevens, L., Yu, Y., Li, X., Stearns, C., Papov, V., Rajotte, D., Li, J. (2005) Sphingosine kinase 1 is a negative regulator of CD4+ Th1 cells. J. Immunol. 175, 6580-6588.